Dermapharm Expands Natural Offering With France's Arkopharma

Germany's Dermapharm will pay €450m to acquire herbal specialist Arkopharma to expand its footprint in Europe's consumer health market in countries such as France, Spain and Italy.

herbal_medicine_scientific_glassware_714778585_1200px
• Source: Shutterstock

Germany-based pharma player Dermapharm Holding SE is poised to expand its dietary supplements and herbals offering with the acquisition of France’s Arkopharma Group.

The firm has submitted a binding offer worth €450m ($465m) for 100% of the shares in Arkopharma’s holding company Apharma...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

Poland’s Formeds Acquired By Private Equity

 
• By 

Enterprise Investors takes 77% stake in Polish clean-label dietary supplements manufacturer Formeds.

Urgo Makes Moves In Poland And Belgium

 
• By 

French consumer health player Urgo has added to its dietary supplements offering with separate deals in Poland and Belgium.

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By 

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.

Haleon Utilizing AI To Develop Natural CHC Products

 
• By 

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

More from Business

Urgo Makes Moves In Poland And Belgium

 
• By 

French consumer health player Urgo has added to its dietary supplements offering with separate deals in Poland and Belgium.

IQVIA Consumer Health: Digestive Category Driving Global OTC Market Growth

 
• By 

An increasing awareness of and interest in gut health helped the global OTC market grow by 4.6% in value terms in 2024, according to IQVIA Consumer Health.

Dermapharm Seeks To Put Stop To Spanish Slide

 
• By 

Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.